Pathogenic variants in genes, which encode DNA repair and damage response proteins, result in a number of genomic instability syndromes with features of accelerated aging. ERCC4 (XPF) encodes a protein that forms a complex with ERCC1 and is required for the 5 ′ incision during nucleotide excision repair. ERCC4 is also FANCQ, illustrating a critical role in interstrand crosslink repair. Pathogenic variants in this gene cause xeroderma pigmentosum, XFE progeroid syndrome,
INTRODUCTION
Genomic instability is associated with many features of aging, including benign and malignant neoplasms. In the last decade or so, many proteins involved in sensing and responding to DNA damage have been characterized, thus enhancing our understanding of genotoxic stress responses. In most cases, genome instability is a consequence of errors made by the enzymes responsible for chromosome segregation, DNA replication, or DNA damage repair (Vijg & Suh, 2013) . A wide range of variants and chromosomal aberrations can activate oncogenes or inactivate tumor suppressor genes and thus increase the risk of cancer (Marteijn, et al., 2014) .
Genomic instability syndromes can also be caused by variants at loci involved in DNA repair, including nucleotide excision repair (NER). NER has two major pathways; global genome NER (GG-NER) and transcription-coupled NER (TC-NER). These pathways are distinguished by their initial DNA damage recognition events (Evans, Moggs, Hwang, Egly, & Wood, 1997; Hanawalt, 2002; Hoeijmakers, 2009; Marteijn, Lans, Vermeulen, & Hoeijmakers, 2014) . Pathogenic variants in these loci can lead to a wide spectrum of disorders that include Cockayne syndrome (CS; MIM# 216400 and 133540), xeroderma pigmentosum (XP; MIM# 278700, 610651, 278720, 278730, 278740, 278760, and 278780) , and trichothiodystrophy (MIM# 616390, 616395, 234050, 616943, 601675, and 300953) . In general, GG-NER causes XP and TC-NER leads to CS, but overlap in the syndromes can occur. CS is commonly caused by mutations in ERCC8 (CSA) or ERCC6 (CSB) and is characterized by microcephaly, neurologic dysfunction, postnatal growth failure, cataracts, enophthalmos, loss of body fat, and skin photosensitivity (Laugel, 2013; Wilson et al., 2016) . XP is characterized by photosensitivity, pigmentary changes, premature skin aging, and a 10,000-fold increased risk of skin cancer (English & Swerdlow, 1987; Kraemer & DiGiovanna, 2014) . The dermatological phenotypes in CS are milder than those of XP. Moreover, skin cancers are not a feature of classical CS.
An XPF endonuclease encoded by ERCC4, also called FANCQ, forms a complex with its regulatory protein encoded by ERCC1 (XPF-ERCC1 complex). XPF-ERCC1 plays an essential role during NER repair that is common to both GG-NER and TC-NER (Friedberg et al., 2006; Schärer, 2013) . In general, patients with constitutional ERCC4 mutations exhibit XP, group F (XP-F; MIM# 278760) (Gregg, Robinson, & Niedernhofer, 2011; Sijbers et al., 1996) . Homozygous or compound heterozygous ERCC4 mutations have also been reported in at least one case of CS, one case of XP-CS (Kashiyama et al., 2013) , two cases of Fanconi anemia, complementation group Q (FANCQ; MIM# 615272) (Bogliolo et al., 2013; Kashiyama et al., 2013) , as well as one case of XFE progeroid syndrome (XFEPS; MIM# 610965) (Niedernhofer et al., 2006 ). There appears to be no consistent genotype-phenotype correlation with the ERCC4 variants (Kashiyama et al., 2013) .
Here, we report on two individuals, one compound heterozygote and the other with two in cis ERCC4 variants, as revealed by massive parallel sequencing. They represent some of the initial results of sequencing efforts to discover novel genetic variants among a series of 42 cases referred to the International Registry of Werner Syndrome (www.wernersyndrome.org) because of some clinical features thought to overlap with those found in the Werner syndrome. After excluding causative variants in loci known to be associated with segmental progeroid phenotypes (including WRN, POLD, and LMNA), these cases were operationally classified as examples of Atypical Werner syndrome (AWS) (Oshima & Hisama, 2014; Oshima, Sidorova, & Monnat, 2016) .
MATERIALS AND METHODS

Subject recruitment and ethical approval
Physicians refer patients they suspect of having a progeroid syndrome to the International Registry of Werner Syndrome Seattle at the University of Washington. After review of a questionnaire and clinical information, appropriate patients (and, when available, their nuclear family members) are enrolled for genetic research studies. All patients must provide written informed consent in order to be enrolled, including permission for the establishment of cell lines. All protocols have been approved by a University of Washington Institutional Review Board.
Candidate gene sequencing
For candidate gene analysis, we designed intronic primers to PCR amplify coding exons and the respective exon-intron boundaries by using genomic DNA from the affected individual. 
Targeted ERCC4 gene sequencing by NGS using long-acting-PCR
Long-acting (LA) PCR was performed to amplify approximately 32 kbp spanning the ERCC4 genomic locus using 100 ng of the probands' genomic DNA. Primer sequences were ERCC4_LA_F (5 ′ -GAGTTCGGCCAACGCTTGCCTTCTC-3 ′ ) and ERCC4_LA_R (5 ′ -GCCAGCTGGACTTAGGGATCTCTG-3 ′ ). PrimeSTAR GXL DNA Polymerase (TaKaRa, Mountain View, CA, USA) was used. Library preparation (Illumina Nextera XT DNA Library Preparation Kit, Illumina, San Diego, CA, USA) was conducted in order to obtain a shotgun-library according to the manufacturer's instructions. Pooled, barcoded libraries were sequenced via paired-end 150-bp reads and an 8-bp barcode read on Illumina MiSeq sequencers. Following basic analysis steps and filtering, conditions for the identification of rare variants were equivalent to that of the exome sequencing as described below.
Exome sequencing in 18 AWS patients and filtering of variants
Exome sequencing was performed with Illumina HiSeq sequencers as previously described (Chong et al., 2015) . Demultiplexed read data (fastq files) were aligned to a human reference sequence (UCSC Genome Browser hg19) via the Burrows-Wheeler Aligner v.0.7.10 (Li & Durbin, 2009 (McLaren et al., 2010) after decomposition and normalization of variants in the raw VCF file with Vt v.0.1.0 (Tan, Abecasis, & Kang, 2015) . Variant filtering was performed with GEMINI (v.0.19.1) (Paila, Chapman, Kirchner, & Quinlan, 2013) . We generated copy-number variant (CNV) calls from exome data by using CoNIFER (Copy Number Inference From Exome Reads) (Krumm et al., 2012) .
Filtering of candidate variants was done as previously described (Chong et al., 2015) . Briefly, we first excluded vari- edu/EVS/), or 1000 Genomes (Abecasis et al., 2010) , as well as variants with allele frequencies >0.05 in an internal database of more than 2,500 exomes. We excluded variants with "LOW" impact severities, as defined by the GEMINI software package (v0.19.1) (Paila et al., 2013) , which includes functional predictions such as: "synonymous_coding," "intergenic," "upstream," "UTR," "intron," and so on. Individual genotypes with a depth <8 or genotype quality <20 were treated as missing. The probands were also screened for larger CNVs via array comparative genomic hybridization on the Illumina Infinium Human-Core-24 BeadChip.
Cell lines and cell culture
Epstein-Barr virus transformed lymphoblastoid cell lines (LCLs) originating from MME1010 were established as previously described (Huang et al., 2006) . Primary human diploid fibroblast cell lines were established from biopsies of skin samples of CALIF1010 and were immortalized with the catalytic subunit of human telomerase (hTERT), as previously described (Saha et al., 2013) 
RT-PCR analysis
RT-PCR was done as described previously (Hisama et al., 2011) .
To evaluate alternative transcription of ERCC4 isoforms caused by variant alleles, we performed RT-PCR reactions. Primer sequences used for amplification of the product spanning exons 1 through 7 in ERCC4 (RefSeq accession NM_005236.2) are XPF_CDS_F (5 ′ -ATGGAGTCAGGGCAGCCGGCTCGAC-3 ′ ) and XPF_CDS_R (5 ′ -GCACAAATCAGTACTTGACCTGGAC-3 ′ ) which are expected to give a wild-type product of 1,232 bp.
For allele-specific RT-PCR in MME1010, two forward primers with variations in their 3 ′ nucleotides were designed so that each primer could be specific for one of the two variants (ERCC4_F_wt
. Two reverse primers were prepared as well as forward primers (ERCC4_R_wt [5 ′ -TCAAG
. By using PCR in combination with each forward and reverse primer, the relative locations of the two variants could be investigated.
Quantitative PCR
Quantitative RT-PCR was used to measure total mRNA level for ERCC4/XPF and ERCC1. Human GAPDH (Fwd:
5 ′ -GCTGGTTTCTGCTCATAGGC-3 ′ ), and ERCC4/XPF (Fwd: 5 ′ -TTTGTGAGGAAACTGTATCTGTGG-3 ′ ; Rev: 5 ′ -GTCTGTATAGCAAG CATGGTAGG-3 ′ ) were analyzed for expression. qPCR reactions were performed on duplicate samples of cDNAs from three independent collections of all cell lines.
Western blot analysis
Western blot analysis was done as described previously (Hisama et al., 2011; Huang et al., 2006) Immunoblot detection was also used to compare expression of XPF in CALIF1010 to that of an established XFE progeroid patient XP51RO (Niedernhofer et al., 2006) . Rabbit -GAPDH antibody (1:10,000) (Sigma Aldrich), ERCC1 mouse monoclonal antibody (D-10) (1:500) (Santa Cruz) and XPF mouse monoclonal antibody (SPM228) (1:1000) (Abcam, Cambridge, MA, USA) were used for detection.
Flow cytometric-based unscheduled DNA synthesis assay
This is a modification of a previously published unscheduled DNA synthesis (UDS) assay (Ahmad et al., 2010) . 1-2 × 10 6 cells were aliquoted and resuspended in an equivalent volume of DPBS. For each cell line, one set of samples were irradiated using the cell culture hood's UV-C lamp in an uncovered petri dish at 24 J/m 2 while being mixed at 300 rpm using an orbital shaker. Samples were then centrifuged and 
Recovery of RNA synthesis
RNA synthesis (RRS) was measured as previously described (VelezCruz, Zadorin, Coin, & Egly, 2013). 1 × 10 5 cells were trypsinized, resuspended in 1 ml of DPBS, and deposited on a 60 mm cell culture dish lid for irradiation with 10 J/m 2 UV-C. After irradiation, the cells were collected, spun down, and replated with complete media then collected at the indicated time points. Total RNA was isolated using Trizol extraction as specified by the manufacturer (Thermo Fisher). cDNA was generated using the Transcriptor First Strand Kit (Roche, Indianapolis, IN, USA) and qRT-PCR was performed on a StepOne thermocycler (Thermo Fisher) using Universal SYBR with ROX (Roche). DHFR and GAPDH mRNA expression was normalized to 18s rRNA and then graphed as the ratio of expression in irradiated cells relative to shamirradiated cells at each time point, as previously described (Velez-Cruz et al., 2013) . Reactions were performed in triplicate and each data point represents the mean of five independent experiments. Human primer sequences included: DHFR Fwd 5 ′ CCACAACCTCTTCAGTAG-
RESULTS
Case presentations
Registry# CALIF1010 is a woman who presented at the age of 35 years for genetic evaluation of microcephaly, enophthalmos and a prematurely aged appearance. She was born at term with a birth weight of 1,820 g and was hospitalized for failure to thrive during infancy.
Childhood photographs of her (at the age of 5 years and later childhood) showed normal skin, eyes, teeth, and hair. She began to wear eye glasses in kindergarten and was intellectually disabled. She required special education and graduated from high school. She developed premature ovarian insufficiency and underwent menopause at age 29 years. All of her teeth were extracted in her 30s. It is unknown whether she had enamel hypoplasia or severe dental caries. She developed bilateral orbital atrophy and enophthalmos. At 35 years of age, her height was normal at 158.5 cm (25th percentile), body weight was 31.1 kg (less than 3rd percentile), and her occipitofrontal circumference was 50.5 cm (<< 3rd percentile). She had an overall premature aged appearance exemplified by thin hair with gray streaks, loss of subcutaneous fat, senile lentigines on the face and hands, and thin, wrinkled, mottled skin. She had a prominent brow, sunken orbits, and was legally blind. Ophthalmological examination showed severe corneal scarring thought to be the cause of her blindness, no cataracts, and no salt-andpepper retinopathy. Hearing loss was not reported, and audiometry was not performed. She was edentulous and she had poor breast development, genital exam was Tanner V. She had thin extremities and bilateral pes cavus. A brain MRI confirmed enophthalmos, brain abnormalities, including white matter lesions. Neither cerebral calcifications nor ventriculomegaly were noted. A cytogenetic analysis was normal (46, XX). The family history revealed a similarly affected sister with intellectual disability, enophthalmos, premature menopause, and complete dental extraction. Consanguinity was denied ( Figure 1A ).
Registry# MME1010 is a 68-year-old Mexican woman with bilateral cataracts (diagnosed at the age of 54 years), tight atrophic skin, graying and thinning of hair (starting at the age of 30 years), type II diabetes mellitus, osteoporosis and an overall aged appearance. Her height was 162 cm and her body weight was 40 kg. Her past history revealed a diagnosis of papillary thyroid cancer at the age of 56 years.
There was no evidence of cognitive impairment or sun sensitivity.
She has a sister who is possibly affected. Parental consanguinity was denied ( Figure 1A ). In an attempt to discover other probands with comparable variants in ERCC4, we screened ERCC4 from an additional 24 genetically undiagnosed Atypical WS patients for whom exome analysis could not be carried out using targeted amplification sequencing with an Illumina Miseq sequencer. This led to the identification of two rare heterozygous ERCC4 variants in an additional proband, CALIF1010.
Next-generation sequencing (NGS) analysis of CALIF1010 revealed a heterozygous missense variant, c.2395C > T (p.Arg799Trp), which has been previously reported as pathogenic (Niedernhofer et al., 2006; Sijbers et al., 1998) . This was confirmed by Sanger sequencing (Figure 1B and Table 1 ). Sequencing analysis also revealed a novel heterozygous genomic deletion spanning from intron 2 through 4, which is expected to cause deletion of exons 3 and 4. Breakpoints of the genomic deletion were determined by genomic PCR using primers designed to amplify the flanking regions. Sequence alignment of the breakpoints confirmed a 5,656 bp deletion spanning introns 2 through 4, c.388+1164_792+795del, which would result in a premature termination, p.Gly130Aspfs*18 ( Figure 1C and D and Table 1 ). The presence of a short sequence, ACT, at both breakpoints suggested an intragenic homologous recombination as the primary mutational mechanism. Parental samples of CALIF1010 were unable to be obtained for additional study to confirm that these variants are in trans. The new pathogenic variants have been submitted to the Leiden Open Variation Database (https://www.lovd.nl/ERCC4).
Molecular analysis of ERCC4 variants
We next investigated mRNA expressions of ERCC4 using the LCL of patient MME1010 and the fibroblasts of patient CALIF1010. As shown in Figure 2A , a faint extra band was detected in CALIF1010, suggesting the presence of a deletion at the mRNA level. Sanger sequencing of this shorter extra band revealed a deletion of exons 3 and 4 ( Figure 2B ), further confirming the presence of a heterozygous deletion in CALIF1010. Levels of the full length mRNA for both ERCC4 and ERCC1 were compared to other patients with ERCC4 mutations and found to be within the normal range ( Figure 3A and B). There have been examples of cryptic splicing generated by nucleotide substitutions in coding regions. Therefore, the possibility of alternative transcripts was evaluated, and absent in MME1010, however, indicating that the novel variants found in MME1010 did not affect splicing.
We then evaluated protein expression of ERCC4/XPF in the probands' LCLs or fibroblasts ( Figure 3C ). Immunoblot detection of ERCC4 protein in the nuclear fraction of cell lysates revealed no difference between MME1010 and normal controls. In contrast, CALIF1010
showed a dramatic reduction of ERCC4 to approximately 6% of the control. This is in agreement with the previous observation that c.2395C > T (p.Arg799Trp) causes protein instability and mislocalization of the mutant protein (Niedernhofer et al., 2006; Sijbers et al., 1998) . Presence of truncated ERCC4 protein corresponding to p.Gly130fs was unable to be determined due to the location of antibody epitope. Comparison of ERCC4 levels in CALIF1010 to that of XP51RO, an XFEPS patient with significant impairment in DNA repair (Ahmad et al., 2010; Niedernhofer et al., 2006) , revealed similar expression levels of ERCC4 in both cell lines ( Figure 3D ). ERCC1 expression levels were also reduced in both progeroid patients demonstrating reduced levels of the DNA repair endonuclease. 
TA B L E 1 Characteristics of the four ERCC4 variants identified in the proband
Cellular consequences of ERCC4 variants
In order to evaluate the functional consequences of the ERCC4 variants found in these two subjects, we measured unscheduled DNA synthesis (UDS) in response to ultraviolet (UV) irradiation. UV-induced UDS (i.e., DNA synthesis in non-replicating cells) is pathognomonic for a defect in NER (Yamaguchi, Mamada, Kondo, & Satoh, 1990) , for which XPF is essential (Sijbers et al., 1996) . For MME1010 LCLs, GM07398
was used as a normal control and set to 100% repair and LB313 XP-F patient cells were used as a control with reduced UDS ( Figure 4A ).
MME1010 had normal levels of UDS following UV irradiation (Fig-
ure 4A and Supp. Figure S1A ), indicating that NER is normal and therefore XPF function is intact. For CALIF1010, C5RO fibroblasts were used as a normal control and set to 100% NER ( Figure 4B ). XP51RO
cells from an XFE progeroid patient and very low UDS (Niedernhofer et al., 2006) were used as a negative control and showed <5% normal UDS. CALIF1010 had <10% normal UDS ( Figure 4B and Supp. Figure S1B) , reflecting a severe defect in NER likely as a consequence of reduced XPF expression.
F I G U R E 3 Expression analysis of XPF-ERCC1 complex.
A: Levels of full-length mRNAs are shown for ERCC4/XPF and ERCC1 as measured by qRT-PCR in CALIF1010 fibroblasts. C5R0 is used as a normal control and set to 1. XP51RO is from a patient with XFE progeroid syndrome caused by a mutation in ERCC4. B: For MME1010 LCL, GM03798 was used as a normal control and set to 1.0. LB313 cells are from an XP-F patient with low but detectable NER capacity. The bar graphs represent the mean values ± SD of the six reactions carried out for each gene. Statistical analysis (one-way ANOVA post hoc test) showed no significant differences in ERCC4 or ERCC1 mRNA levels among patients and control cell lines. C: Western blot analysis of nuclear fractions of cells of patients' LCL and fibroblast cells showing levels of ERCC4, LMNA, and -actin. LMNA used was used as a marker for nuclei and -actin was utilized as an additional loading control. Control 1 and control 2 correspond to extracts from control LCLs and fibroblasts, respectively. D: Immunodetection of ERCC4 and ERCC1 in healthy donor fibroblasts (C5RO) and cells from an ERCC4 progeroid patient (XP51RO) and the new CALIF1010 patient. GAPDH was used as the loading control. Both ERCC4 and ERCC1 protein levels are substantially lower in both progeroid patients compared to controls
To test the impact of the ERCC4 mutations on interstrand crosslink (ICL) repair, we determined the cellular sensitivities to MMC, to which Relative to these positive and negative controls, MME1010 has normal NER capacity. B: In fibroblasts, C5RO represents normal NER of UV-induced DNA damage. XP51RO is a negative control from an XFE progeroid patient reported to have a UDS of <5% (Niedernhofer et al., 2006) . UDS levels were significantly reduced in the CALIF1010 cells compared with the positive control, consistent with substantial impairment in NER F I G U R E 5 Cellular sensitivity to mitomycin C as an index of capacity for interstrand crosslink repair. Cells were treated with the indicated concentrations of MMC ( M) for 24 hr (A and C) or 4 days (B and D). Cell counts were normalized to that of untreated cultures to obtain survival data. Standard deviations were calculated from the results of 3 experiments. * indicates the statistical significance of t-tests control cultures ( Figure 5B ). For MEM1010, there was no difference in survivals compared with control LCL under the same conditions ( Figure 5C and D) . Together, these results support a conclusion that the ERCC4 variants found in CALIF1010 are indeed responsible for progeroid features of the patient, but that the ERCC4 variants found in MME1010 are unlikely to be pathogenic.
F I G U R E 6
Recovery of RNA synthesis after UV irradiation is impaired in CALIF1010 and CS patient cell lines. mRNA expression of DHFR and GAPDH was measured in the indicated cell lines after UV irradiation (10 J/m 2 ). Expression was normalized to the amount of 18s rRNA and the results are plotted as the ratio of expression in irradiated vs. sham-irradiated cells. Each data point represents the mean of three qPCR reactions of five independent experiments. Error bars represent the SD. One-way ANOVA, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001
The recovery of RRS post-UV irradiation is a measure of transcription-coupled NER, which is specifically impaired in cells from CS patients (Andrade-Lima, Veloso, Paulsen, Menck, & Ljungman, 2015) . Since mutations in ERCC4 have been linked to CS (Kashiyama et al., 2013) , RRS was measured in CALIF1010 at several time points following UV irradiation of the cells. Expression of the housekeeping genes DHFR and GAPDH were used in RRS as previously described (Velez-Cruz et al., 2013) . Normal fibroblasts (C5RO) were used as a negative control, while CS20LO cells from a patient with CS due to a mutation in ERCC1 (Kashiyama et al., 2013) 
Structural analysis of ERCC4 variants
The ERCC4 endonuclease consists of an N-terminal domain with distant homology to DNA helicases of superfamily 2, a central domain containing the nuclease active site, and a C-terminal tandem helixhairpin-helix (HhH) 2 domain (Sgouros, Gaillard, & Wood, 1999) . As shown in Figure 7A , the previously reported ERCC4 mutations are widely distributed over the entire length of the protein. ERCC4
and ERCC1 have sequence similarities in their central and nuclease domains, and in their HhH domains (Gaillard & Wood, 2001 ).
p.Arg799Trp, which is found in CALIF1010, has been reported to be a causal "hot spot" for XP-F (Ahmad et al., 2010; Sijbers et al., 1998) . The other frame-shift variant of CALIF1010, p.Gly130Aspfs*18, is located near the N-terminus and resulted in the shortest ERCC4 transcript so far reported. The altered amino acids are highly conserved among various species ( Figure 7B ).
In MME1010, the p.Gln496His variant is located outside the disrupted helicase domain, where several XP and FA mutations have been reported ( Figure 7A ). Structural analysis predicted that the p.Gln496His variant is likely benign and would only affect protein function if the Gln side chain were a component of an active site or a binding site for an interacting protein ( Figure 7B ). In contrast, the pAla860Asp variant of MME1010 is within the (HhH) 2 domain ( Figure 7A ). The two functions of (HhH) 2 domain are heteroduplex formation with ERCC1
and DNA binding, both of which are very important for structural and functional integrity of the XPF-ERCC1 endonuclease (Das et al., 2012; Faridounnia et al., 2015; Tripsianes et al., 2005; Tsodikov, et al., 2005) .
pAla860Asp is located at the C-terminal of -helix in this interaction domain adjacent to a DNA binding site of ERCC4 (hairpin h 1 , and Lys 861 ) (Das et al., 2012) , residue numbers adapted to the most recent residue numbering in ERCC4/XPF ( Figure 7C ). Based on helix propensity data, p.Ala860Asp substitution could alter the helix stability, leading to altered DNA binding properties, and/or a side-chain occupancy less likely to accommodate DNA substrates. Nevertheless, MME1010
cells had an NER capacity equivalent to normal cells ( Figure 4A ) and normal sensitivity to the crosslinking agent MMC ( Figure 5C and D).
Thus, either the second allele of ERCC4 is adequate to compensate for the p.Ala860Asp allele, or the p.Ala860Asp allele is benign and does not affect XPF function. We favor the former based on the observation that in mice, one copy of Xpf is adequate to support normal expression of the gene and to confer resistance to UV and MMC (Tian, Shinkura, Shinkura, & Alt, 2004) .
DISCUSSION
Genomic instability is not only a cause of various cancers but is also suspected to be a major driver of human aging. NGS in 42 unsolved AWS patients revealed two cases, each of which had two heterozygous ERCC4 mutations. Both patients showed several features consistent with accelerated aging.
To the best of our knowledge, there has been no previous report of exon deletions within the ERCC4 gene. Our breakpoint analysis of the deletion mutation in CALIF1010 suggests that common ACT sequence-mediated intragenic recombination may be the mechanism underlying the ERCC4 deletion mutation. A similar mechanism has been reported for other loci which undergo non-allelic homologous F I G U R E 7 Distribution of the reported ERCC4 variants and conservation of the Gln496, Ala860, and Arg799 amino acids throughout evolution. A: The structural domains in ERCC4 and the locations of amino acid alterations in previously reported patients. XP pathogenic variants are grouped above the functional domains. Pathogenic variants reported in other conditions are shown above the XP variants along with the corresponding diagnosis. ERCC4 includes an N-terminal disrupted helicase domain and a nuclease domain. The C-terminal domain, including the nuclease domain and helix-hairpin-helix (HhH) motifs, shows similarity to that of ERCC1. Double-lined squares show the variants found in MME1010 and CALIF1010. B: Conservation of the altered amino acids. Amino acids colored in gray indicate conservation between groups of highly similar properties. C: A proposed model for the impact of the MME1010 patient's variant residing in the HhH domain of ERCC4. This C-terminal part of the protein is critical for interaction with ERCC1 and for heteroduplex stability. ERCC4/XPF in green. ERCC1 is represented in blue. The red spheres represent the mutant residue Asp860. The overlapping stick representation in orange represents the wild-type residue Ala860 superimposed, illustrating little structural deformity caused by the variant. The model was generated using Mutagenesis wizard of Pymol visualization software. The model was calculated on HADDOCK web server for electrostatics, desolvation and van der Waals energy refinement van Zundert et al., 2016) recombination following ectopic cross-over of repeat sequences (Liu, Carvalho, Hastings, & Lupski, 2012; Oshima et al., 2009 ).
The majority of pathogenic ERCC4 mutations present as XP-F and are characterized by relatively late onset of skin manifestation including increased sun sensitivity and skin cancer (Gregg et al., 2011; Sijbers et al., 1996) . Cases of CS without any features of XP are quite rare among ERCC4 mutants (Kashiyama et al., 2013) . There are indeed rare cases that show features of both CS and XP, referred to as combined XP-CS (Kashiyama et al., 2013) . XP-CS individuals present with skin phenotypes common in XP patients, including severe photosensitivity, abnormal skin pigmentation, and skin cancer; additional features include developmental abnormalities common in CS patients. Although CS is associated with only TC-NER-specific defects, XP-CS is caused by the defects within both TC-NER and GG-NER.
The recently published Cockayne Syndrome Natural History Study (Wilson et al., 2016) GG-NER, but unlike ERCC4, it generates a 3 ′ incision following UVinduced damage (Ito et al., 2007) .
CALIF1010 carries obligatory compound heterozygous mutations in ERCC4 and exhibited dramatically reduced ERCC4 protein expression. The frame-shift deletion of exon 3 and 4 (p.Gly130Aspfs*18) resulted in null expression of XPF. Sijbers et al. (1998) reported that homozygosity for p.Arg799Trp is also associated with markedly reduced XPF expression . The major clinical features of CALIF1010 consist of early failure to thrive, and marked microcephaly, followed by development of sunken eyes, cognitive impairment, progressive loss of body fat, and premature aging of the skin. CALIF1010, therefore, appears to be the second case report of a patient with a Cockayne-like syndrome without XP and with progeroid features caused by biallelic ERCC4 variants (Kashiyama et al., 2013 ).
MME1010 carries two novel variants in cis in ERCC4. CADD scores (Kircher et al., 2014) , which are utilized for pathogenicity predic- As summarized in Figure 7A , there appears to be no clear correlation between the clinical phenotypes and locations of ERCC4 variants. Moreover, cellular disease phenotypes are not always consistent. Bogliolo et al. (2013) reported one FA case with biallelic ERCC4 variants, p.Thr495Asnfs*6 and p.Arg689Ser, without any skin and neurological phenotypes, concluding that FA-causing ERCC4 pathogenic variants disrupt the ERCC4 function in DNA ICL repair without severely compromising NER (Bogliolo et al., 2013) . These findings raise the possibility of modifying loci not only for clinical presentations but also for cellular disease phenotypes.
